Related Articles
Clinical and molecular assessment of regorafenib monotherapy
HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer
Dynamics of circulating tumor cells in early breast cancer under neoadjuvant therapy
Transcriptional profiling of circulating tumor cells: Quantification and cancer progression (Review)
Prognostic relevance of tumor‑infiltrating lymphocytes in residual tumor tissue from patients with triple‑negative breast cancer following neoadjuvant chemotherapy: A systematic review and meta‑analysis